celecoxib has been researched along with ganciclovir in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baryawno, N; Darabi, A; FuskevÅg, OM; Johnsen, JI; Khan, Z; Kogner, P; Nordenskjöld, M; Odeberg, J; Rahbar, A; Segerström, L; Siesjö, P; Söderberg-Nauclér, C; Sveinbjörnsson, B; Taher, C; Wolmer-Solberg, N | 1 |
| Bishehsari, F; De Fabritiis, S; Lattanzio, R; Mahdavinia, M; Mariani-Costantini, R; Martin Almazan, N; Pantalone, MR; Rahbar, A; Söderberg-Naucler, C; Taher, C; Valentinuzzi, S; Verginelli, F | 1 |
1 review(s) available for celecoxib and ganciclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for celecoxib and ganciclovir
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target.
Topics: Adult; Animals; Antiviral Agents; Brain Neoplasms; Celecoxib; Cell Line, Tumor; Child; Child, Preschool; Cyclooxygenase 2 Inhibitors; Cytomegalovirus; Dinoprostone; Female; Ganciclovir; Humans; Infant; Male; Medulloblastoma; Mice; Mice, Nude; Middle Aged; Pyrazoles; Sulfonamides; Valganciclovir; Virus Replication; Xenograft Model Antitumor Assays; Young Adult | 2011 |
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer.
Topics: Arachidonate 5-Lipoxygenase; Caco-2 Cells; Celecoxib; Colorectal Neoplasms; Cyclooxygenase 2; Cytomegalovirus; Cytomegalovirus Infections; ErbB Receptors; Ganciclovir; Humans; Ki-67 Antigen; Proto-Oncogene Proteins p21(ras) | 2023 |